Your browser doesn't support javascript.
SARS-CoV-2/COVID-19 pandemic: first wave, impact, response and lessons learnt in a fully integrated Regional Blood and Tissue Bank. A narrative report.
Garcia-Lopez, Joan; Delgadillo, Joaquin; Vilarrodona, Anna; Querol, Sergi; Ovejo, Joan; Coll, Ruth; Millan, Anna; Madrigal, Alejandro; Soria, Gloria; Vidal, Francisco; Vives, Joaquim; Herrero, María J; Lopez, Isabel; Sauleda, Silvia; Contreras, Enric; Grifols, Joan Ramon; Guasch, Rosa; Tahull, Elisabet; Puig, Lluís; Masip, Aurora; Argelagués, Enric; Muñiz-Diaz, Eduardo.
  • Garcia-Lopez J; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Delgadillo J; Chair of Transfusion Medicine and Cellular and Tissue Therapies, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Vilarrodona A; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Querol S; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Ovejo J; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Coll R; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Millan A; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Madrigal A; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Soria G; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Vidal F; UCL Cancer institute, Royal Free Hospital, London, United Kingdom.
  • Vives J; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Herrero MJ; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Lopez I; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Sauleda S; Chair of Transfusion Medicine and Cellular and Tissue Therapies, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Contreras E; Musculoskeletal Tissue Engineering Group, Vall d'Hebron Research Institute (VHIR), Barcelona, Spain.
  • Grifols JR; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Guasch R; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Tahull E; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Puig L; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Masip A; Chair of Transfusion Medicine and Cellular and Tissue Therapies, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.
  • Argelagués E; Banc de Sang i Teixits (BST), Barcelona, Spain.
  • Muñiz-Diaz E; Banc de Sang i Teixits (BST), Barcelona, Spain.
Blood Transfus ; 19(2): 158-167, 2021 03.
Article in English | MEDLINE | ID: covidwho-1067610
ABSTRACT

BACKGROUND:

The COVID-19 pandemic is placing blood and tissue establishments under unprecedented stress, putting its capacity to provide the adequate care needed at risk. Here we reflect on how our integrated organisational model has faced the first impact of the pandemic and describe what challenges, opportunities and lessons have emerged. MATERIALS AND

METHODS:

The organisational model of the Catalan Blood and Tissue Bank (Banc de Sang i Teixits, BST) is described. The new scenario was managed by following international recommendations and considering the pandemic in a context of volatility, uncertainty, complexity, and ambiguity (VUCA), allowing rapid measures to be taken. These aimed to ensure donor safety, promote proper responses to patients' needs, ensure the health and well-being of personnel, and prepare for future scenarios.

RESULTS:

The BST has adapted its activities to the changes in demand. No shortage of any product or service occurred. Donor acceptance, safety and wellbeing were maintained except for tissue donation, which almost completely stopped. To support the health system, several activities have been promoted large-scale convalescent plasma (CP) production, clinical trials with CP and mesenchymal stromal cells, massive COVID-19 diagnoses, and participation in co-operative research and publications. Haemovigilance is running smoothly and no adverse effects have been detected among donors or patients.

DISCUSSION:

Several elements have proven to be critical when addressing the pandemic scenario a) the early creation of a crisis committee in combination with technical recommendations and the recognition of a VUCA scenario; b) identification of the strategies described; c) the integrated donor-to-patient organisational model; d) active Research and Development (R&D); and e) the flexibility of the staff. It is essential to underline the importance of the need for centralised management, effective contingency strategies, and early collaboration with peers.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tissue Banks / Blood Banks / Pandemics / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Blood Transfus Year: 2021 Document Type: Article Affiliation country: 2021.0259-20

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Tissue Banks / Blood Banks / Pandemics / SARS-CoV-2 / COVID-19 Type of study: Experimental Studies / Observational study / Prognostic study Limits: Humans Country/Region as subject: Europa Language: English Journal: Blood Transfus Year: 2021 Document Type: Article Affiliation country: 2021.0259-20